SCBIO Co., Ltd
- Biotech or pharma, therapeutic R&D
SCBIO is a clinical-stage pharmaceutical company focused on the development of small molecule modulators targeting the tumor microenvironment as immuno-oncology drugs and fibrotic diseases such as idiopathic pulmonary fibrosis (IPF). SCBIO is developing a diversified pipeline of Best-in-Class and First-in-Class small molecule assets.
)
)
){kind=logo}
){kind=logo}
){kind=logo}